Activity in this selectionshanghai-sci-tech-innovation-center-capital-3ee5f24c
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $120M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionAusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B
Role not disclosed